Elevated levels of circulating complexes, which are formed by oxidatively modified low density lipoproteins (oxLDL) and β2GPI (oxLDL/β2GPI) and recognized by anti-β2GPI, were found to be associated with the increased risk of arterial thrombosis in APS and SLE patients (146). This evidence concerns the gene APOH and Arterial thrombosis.